CRDL — Cardiol Therapeutics Inc.

—
Nasdaq · Health Care · Biotechnology · CIK 1702123 ·
Last close
$0.97
Market Cap
$113.53M
52W High
$2.34
52W Low
$0.88
ADV30
798,230
Next earnings
2026-11-12

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -9,801,999 -13,324,604 32,885,787 29,229,802 5,282,533
Jun 2026 0 — -7,937,921 -6,081,827 29,357,847 26,081,066 5,328,926
Mar 2026 0 — -9,706,794 -10,818,589 31,406,607 27,673,191 7,203,302
Dec 2025 0 — -8,030,975 -7,212,569 23,619,933 21,416,684 5,742,215

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-24,047,119
Investing CF
$-56,720
Financing CF
$31,610,015
CapEx
$-56,720
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.37
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-229,973,391
Inventory
—
Receivables
$312,611
ST Investments
—
EBIT TTM
$-35,855,790
Pretax Income TTM
$-34,077,266
Interest Exp TTM
—
Analysts
5

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -34,316,296 -33,818,874 23,619,933 5,742,215 17,877,718 -23,854,650
Dec 2024 0 -40,276,651 -36,677,299 31,863,751 7,135,268 24,728,483 -25,060,867
Dec 2023 0 -29,785,504 -28,128,292 36,700,508 8,454,001 28,246,507 -25,180,441
Dec 2022 0 -41,335,878 -30,930,647 62,028,518 9,826,930 52,201,588 -27,220,345

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.24

Max Pain — expiry 2027-06-17 (volume-derived — Yahoo OI feed degraded)

max pain strike: $1.50 · spot: $0.95 · call volume: 2 · put volume: 20

Peers — same industry

TickerNameMarket CapLastDaily %
ENGN enGene Therapeutics Inc. $115.27M $1.72 —
LENZ LENZ Therapeutics, Inc. $109.97M $3.50 —
MOLN MOLECULAR PARTNERS AG $109.55M $2.86 —
CMPX Compass Therapeutics, Inc. $109.26M $0.61 —
FATE FATE THERAPEUTICS INC $124.00M $1.02 —

News headlines (Yahoo Finance, 1h cache)

Cardiol Therapeutics Announces At-The-Market Equity Offering Program With Jefferies LLC
2026-11-03 22:00 · Yahoo
Cardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial to Strengthen Assessment of CardiolRx™'s Efficacy
2026-09-23 10:00 · Yahoo
Cardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in Proceeds
2026-09-16 11:27 · Yahoo
Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus Including Additional Disclosure Following Review by Staff of the Ontario Securities Commission
2026-09-10 21:00 · Yahoo
Cardiol Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference
2026-09-09 11:27 · Yahoo
Is Cardiol Therapeutics (CRDL) Stock Outpacing Its Medical Peers This Year?
2026-08-25 13:40 · Yahoo
Cardiol Therapeutics Inc. (CRDL) is a Great Momentum Stock: Should You Buy?
2026-08-24 16:00 · Yahoo
Cardiol Therapeutics Advances CardiolRx in Pivotal Phase III Pericarditis Trial
2026-08-12 12:01 · Yahoo
5 Small Drug Stocks Poised to Benefit From a Biotech Recovery
2026-09-14 13:30 · Yahoo
Is Aspen Pharmacare (APNHY) Outperforming Other Medical Stocks This Year?
2026-09-10 13:40 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.